| Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis. | |
| | |
MedLine Citation:
|
PMID: 21915772 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Neurocysticercosis (NCC) is the most frequent parasitic disease of the human brain. Modern imaging studies, CT and MRI, have defined the diagnosis and characterization of the disease. Through these studies the therapeutic approach for each case may be individualized with the aid of antihelmintics, steroids, symptomatic medicines, or surgery. The use of one or various therapeutic measures largely depends on the peculiar combination of number, location, and biological stage of lesions as well as the degree of inflammatory response to the parasites. Although there is not a typical clinical picture of NCC, epilepsy is the most frequent manifestation of parenchymal NCC, whereas hydrocephalus is the most frequent manifestation of meningeal NCC. Eradication of cysticercosis is an attainable goal by public education and sanitary improvement in endemic areas. |
| | |
Authors:
|
Julio Sotelo |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-15 |
Journal Detail:
|
Title: Current neurology and neuroscience reports Volume: - ISSN: 1534-6293 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100931790 Medline TA: Curr Neurol Neurosci Rep Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
The Neuroimmunology Unit, National Institute of Neurology and Neurosurgery of Mexico, Insurgentes Sur 3877, Mexico City, 14269, Mexico, jsotelo@unam.mx. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor ...
Next Document: Pathogenesis of Shiga-Toxin Producing Escherichia coli.